martes, 18 de febrero de 2020

STAT Plus: A longtime health care investor recalls the insulin bong, praises discipline in valuations, and looks to South America

https://www.statnews.com/2020/02/14/a-longtime-health-care-investor-recalls-the-insulin-bong-praises-discipline-in-valuations-and-looks-to-south-america/?utm_source=STAT+Newsletters&utm_campaign=879c358133-Cancer_Briefing&utm_medium=email&utm_term=0_8cab1d7961-879c358133-149692869
Cancer Briefing

STAT Plus: A longtime health care investor recalls the insulin bong, praises discipline in valuations, and looks to South America

By ADAM FEUERSTEIN AND DAMIAN GARDE AND REBECCA ROBBINS

SPENCER PLATT/GETTY IMAGES
"Back in the ’90s, biotech investing was the Wild West. We didn't have the sophisticated scientist folks creating companies or analyzing companies."

No hay comentarios: